Indication
End-Stage Liver Disease
3 clinical trials
3 products
Product
LYG-LIV0001Clinical trial
A Phase 2a, Open Label, Dose Escalation Study for Safety, Tolerability, and Efficacy of Hepatocyte Transplantation Into Periduodenal Lymph Nodes Among Subjects With End-Stage Liver DiseaseStatus: Recruiting, Estimated PCD: 2026-02-22
Clinical trial
Quantitative Liver Function Tests Using CholatesStatus: Active (not recruiting), Estimated PCD: 2025-12-01
Product
CholatesClinical trial
Tocotrienol Against the Progression of End Stage Liver DiseaseStatus: Recruiting, Estimated PCD: 2028-12-31
Product
Tocotrienol